Literature DB >> 23701866

Modulation of behavior by scaffolding proteins of the post-synaptic density.

Can Gao1, Natalie C Tronson, Jelena Radulovic.   

Abstract

Scaffolding proteins of the neuronal post-synaptic density (PSD) are principal organizers of glutamatergic neurotransmission that bring together glutamate receptors and signaling molecules at discrete synaptic locations. Genetic alterations of individual PSD scaffolds therefore disrupt the function of entire multiprotein modules rather than a single glutamatergic mechanism, and thus induce a range of molecular and structural abnormalities in affected neurons. Despite such broad molecular consequences, knockout, knockdown, or knockin of glutamate receptor scaffolds typically affect a subset of specific behaviors and thereby mold and specialize the actions of the ubiquitous glutamatergic neurotransmitter system. Approaches designed to control the function of neuronal scaffolds may therefore have high potential to restore behavioral morbidities and comorbidities in patients with psychiatric disorders. Here we summarize a series of experiments with genetically modified mice revealing the roles of main N-methyl-d-aspartate (NMDA) and group I metabotropic glutamate (mGluR1/5) receptor scaffolds in behavior, discuss the clinical implications of the findings, and propose future research directions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Glutamate receptor; Psychiatric disorders; Scaffold

Mesh:

Substances:

Year:  2013        PMID: 23701866      PMCID: PMC3769443          DOI: 10.1016/j.nlm.2013.04.014

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  128 in total

1.  Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.

Authors:  Michael Feyder; Rose-Marie Karlsson; Poonam Mathur; Matthew Lyman; Roland Bock; Reza Momenan; Jeeva Munasinghe; Maria Luisa Scattoni; Jessica Ihne; Marguerite Camp; Carolyn Graybeal; Douglas Strathdee; Alison Begg; Veronica A Alvarez; Peter Kirsch; Marcella Rietschel; Sven Cichon; Henrik Walter; Andreas Meyer-Lindenberg; Seth G N Grant; Andrew Holmes
Journal:  Am J Psychiatry       Date:  2010-10-15       Impact factor: 18.112

2.  Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions.

Authors:  Terunaga Nakagawa; Kensuke Futai; Hilal A Lashuel; Irene Lo; Kenichi Okamoto; Thomas Walz; Yasunori Hayashi; Morgan Sheng
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

3.  Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD.

Authors:  Weifeng Xu; Oliver M Schlüter; Pascal Steiner; Brian L Czervionke; Bernardo Sabatini; Robert C Malenka
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

4.  The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.

Authors:  Q Wang; E I Charych; V L Pulito; J B Lee; N M Graziane; R A Crozier; R Revilla-Sanchez; M P Kelly; A J Dunlop; H Murdoch; N Taylor; Y Xie; M Pausch; A Hayashi-Takagi; K Ishizuka; S Seshadri; B Bates; K Kariya; A Sawa; R J Weinberg; S J Moss; M D Houslay; Z Yan; N J Brandon
Journal:  Mol Psychiatry       Date:  2010-09-14       Impact factor: 15.992

5.  Common variants on chromosome 6p22.1 are associated with schizophrenia.

Authors:  Jianxin Shi; Douglas F Levinson; Jubao Duan; Alan R Sanders; Yonglan Zheng; Itsik Pe'er; Frank Dudbridge; Peter A Holmans; Alice S Whittemore; Bryan J Mowry; Ann Olincy; Farooq Amin; C Robert Cloninger; Jeremy M Silverman; Nancy G Buccola; William F Byerley; Donald W Black; Raymond R Crowe; Jorge R Oksenberg; Daniel B Mirel; Kenneth S Kendler; Robert Freedman; Pablo V Gejman
Journal:  Nature       Date:  2009-07-01       Impact factor: 49.962

6.  Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein.

Authors:  Geneviève Leuba; Armand Savioz; André Vernay; Béatrice Carnal; Rudolf Kraftsik; Eric Tardif; Irène Riederer; Béat Michel Riederer
Journal:  J Alzheimers Dis       Date:  2008-09       Impact factor: 4.472

7.  Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression.

Authors:  Beata Karolewicz; Katalin Szebeni; Tempestt Gilmore; Dorota Maciag; Craig A Stockmeier; Gregory A Ordway
Journal:  Int J Neuropsychopharmacol       Date:  2008-06-23       Impact factor: 5.176

8.  Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling.

Authors:  M Behnam Ghasemzadeh; Lindsay K Windham; Russell W Lake; Christopher J Acker; Peter W Kalivas
Journal:  Synapse       Date:  2009-01       Impact factor: 2.562

9.  Kalirin-7 is required for synaptic structure and function.

Authors:  Xin-Ming Ma; Drew D Kiraly; Eric D Gaier; Yanping Wang; Eun-Ji Kim; Eric S Levine; Betty A Eipper; Richard E Mains
Journal:  J Neurosci       Date:  2008-11-19       Impact factor: 6.167

10.  PSD-95 promotes synaptogenesis and multiinnervated spine formation through nitric oxide signaling.

Authors:  Irina Nikonenko; Bernadett Boda; Sylvain Steen; Graham Knott; Egbert Welker; Dominique Muller
Journal:  J Cell Biol       Date:  2008-12-15       Impact factor: 10.539

View more
  21 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

2.  Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.

Authors:  Kathy Sengmany; Junaid Singh; Gregory D Stewart; P Jeffrey Conn; Arthur Christopoulos; Karen J Gregory
Journal:  Neuropharmacology       Date:  2016-07-05       Impact factor: 5.250

3.  Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.

Authors:  Jerri M Rook; Zixiu Xiang; Xiaohui Lv; Ayan Ghoshal; Jonathan W Dickerson; Thomas M Bridges; Kari A Johnson; Daniel J Foster; Karen J Gregory; Paige N Vinson; Analisa D Thompson; Nellie Byun; Rebekah L Collier; Michael Bubser; Michael T Nedelcovych; Robert W Gould; Shaun R Stauffer; J Scott Daniels; Colleen M Niswender; Hilde Lavreysen; Claire Mackie; Susana Conde-Ceide; Jesus Alcazar; José M Bartolomé-Nebreda; Gregor J Macdonald; John C Talpos; Thomas Steckler; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  Neuron       Date:  2015-04-30       Impact factor: 17.173

4.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-05-28       Impact factor: 6.186

5.  Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Authors:  Jordi Soler; Lourdes Fañanás; Mara Parellada; Marie-Odile Krebs; Guy A Rouleau; Mar Fatjó-Vilas
Journal:  J Psychiatry Neurosci       Date:  2018-07       Impact factor: 6.186

Review 6.  Proteomic Analysis of Postsynaptic Protein Complexes Underlying Neuronal Plasticity.

Authors:  Anthony J Baucum
Journal:  ACS Chem Neurosci       Date:  2017-02-23       Impact factor: 4.418

7.  The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues.

Authors:  Christina J Perry; Felicia Reed; Isabel C Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

8.  Parkin Deficiency Reduces Hippocampal Glutamatergic Neurotransmission by Impairing AMPA Receptor Endocytosis.

Authors:  Giuseppe P Cortese; Mei Zhu; Damian Williams; Sarah Heath; Clarissa L Waites
Journal:  J Neurosci       Date:  2016-11-30       Impact factor: 6.167

9.  An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.

Authors:  Darrick T Balu; Yan Li; Shunsuke Takagi; Kendall Taylor Presti; Teniel S Ramikie; Jerri M Rook; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn; Vadim Y Bolshakov; Joseph T Coyle
Journal:  Neuropsychopharmacology       Date:  2016-01-07       Impact factor: 7.853

Review 10.  The Endocannabinoid Signaling System in the CNS: A Primer.

Authors:  Cecilia J Hillard
Journal:  Int Rev Neurobiol       Date:  2015-11-06       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.